Inventor · Vélizy-Villacoublay, FR

Philippe Langella

12Patents
1h-index
36Co-inventors
46Inventor score

Filing activity: Sep 18, 2014 → Jun 22, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US10238697B2 Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics Human Necessities 2 Active
US10736927B2 Pharmaceutical compositions for preventing or treating inflammatory bowel diseases Emerging Cross-Sectional Technologies 1 Active
US10328132B2 Compositions for the inhibition of Giardia lamblia Emerging Cross-Sectional Technologies 1 Active
US9688742B2 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) Chemistry; Metallurgy 1 Active
US11166991B2 Bacterial strain as agents for preventing and/or treating respiratory disorders Chemistry; Metallurgy 0 Active
US11596657B2 Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders Emerging Cross-Sectional Technologies 0 Active
US11207358B2 Probiotic composition comprising Lactobacillus rhamnosus and Lactobacillus paracasei and methods thereof Chemistry; Metallurgy 0 Active
US11717543B2 Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain Chemistry; Metallurgy 0 Active
US10918678B2 Faecalibacterium prausnitzii strain CNCM 1-4573 for the treatment and prevention of gastrointestinal inflammation Chemistry; Metallurgy 0 Active
US11013783B2 Anti-inflammatory peptides and methods for treating inflammatory diseases Human Necessities 0 Active
US11103564B2 Compositions for the inhibition of Giardia lamblia Emerging Cross-Sectional Technologies 0 Active
US11471498B2 Probiotic strain of Lactobacillus brevis Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.